News
US inspectors have uncovered breakdowns in drugmaking at an Indian factory owned by Sun Pharma that produces generic medications for American consumers.
Prognostic Nutritional Index and systemic oxidative stress scores are associated with prognosis in patients with low-risk MDS, data suggest.
The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.
Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.
The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...
Resources available to clinical research physicians and the expectations placed upon these individuals vary across cancer cancers, data suggest.
Researchers recommend that details on prescription medications received in the year before diagnosis and treatment initiation be included in clinical trials as essential baseline information.
This analysis indicates that proposed Medicaid reforms would have far-reaching consequences beyond federal budget savings, including negative health outcomes, economic losses, and health care system ...
The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.
Researchers assessed the global burden of breast cancer in boys and men aged 15-64 years between 1990 and 2021.
Researchers recommended that regulators consider mandating head-to-head trials comparing next-in-class and against existing in-class agents when possible.
The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health care workers alike.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results